These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8354514)

  • 21. Antidepressant-induced hypomania in obsessive-compulsive disorder.
    Rihmer Z; Barsi J; Belsõ N; Pestality P; György S
    Int Clin Psychopharmacol; 1996 Sep; 11(3):203-5. PubMed ID: 8923100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of serotonin and dopamine in the pathophysiology of obsessive compulsive disorder.
    Goodman WK; McDougle CJ; Price LH
    Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():35-8. PubMed ID: 1517555
    [No Abstract]   [Full Text] [Related]  

  • 23. Paranoid and aggressive behavior in two obsessive-compulsive adolescents treated with clomipramine.
    Alarcon RD; Johnson BR; Lucas JP
    J Am Acad Child Adolesc Psychiatry; 1991 Nov; 30(6):999-1002. PubMed ID: 1757451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
    Piccinelli M; Pini S; Bellantuono C; Wilkinson G
    Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quetiapine treatment in a patient with Tourette's syndrome, obsessive-compulsive disorder and drug-induced mania.
    Matur Z; Uçok A
    Isr J Psychiatry Relat Sci; 2003; 40(2):150-2. PubMed ID: 14509206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacotherapy of obsessive compulsive disorder.
    Goodman WK; McDougle CJ; Price LH
    J Clin Psychiatry; 1992 Apr; 53 Suppl():29-37. PubMed ID: 1532962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder.
    Diniz JB; Costa DL; Cassab RC; Pereira CA; Miguel EC; Shavitt RG
    J Psychopharmacol; 2014 Jun; 28(6):603-11. PubMed ID: 24288238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin-uptake inhibitors in obsessive-compulsive disorder: a case report.
    White K; Keck PE; Lipinski J
    Compr Psychiatry; 1986; 27(3):211-4. PubMed ID: 3458554
    [No Abstract]   [Full Text] [Related]  

  • 29. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
    Jenike MA; Hyman S; Baer L; Holland A; Minichiello WE; Buttolph L; Summergrad P; Seymour R; Ricciardi J
    Am J Psychiatry; 1990 Sep; 147(9):1209-15. PubMed ID: 2143637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluvoxamine withdrawal syndrome.
    Szabadi E
    Br J Psychiatry; 1992 Feb; 160():283-4. PubMed ID: 1540778
    [No Abstract]   [Full Text] [Related]  

  • 31. When fluvoxamine treats only depression and clomipramine treats only obsessive-compulsive disorder--combine them?
    Schaller JL; Behar D; Chamberlain T
    J Neuropsychiatry Clin Neurosci; 1998; 10(1):111-3. PubMed ID: 9547477
    [No Abstract]   [Full Text] [Related]  

  • 32. A pilot study of biological predictors of treatment outcome in obsessive-compulsive disorder.
    Hollander E; Stein DJ; DeCaria CM; Saoud JB; Klein DF; Liebowitz MR
    Biol Psychiatry; 1993 May; 33(10):747-9. PubMed ID: 8353170
    [No Abstract]   [Full Text] [Related]  

  • 33. Tardive dyskinesia associated with fluoxetine.
    Sandler NH
    J Clin Psychiatry; 1996 Feb; 57(2):91. PubMed ID: 8591977
    [No Abstract]   [Full Text] [Related]  

  • 34. [A manic episode in a female patient with obsessive-compulsive disorder treated with chlorimipramine].
    Bernardo M; Vieta E; Vallejo J
    Med Clin (Barc); 1989 Oct; 93(10):395. PubMed ID: 2607791
    [No Abstract]   [Full Text] [Related]  

  • 35. Obsessive compulsive disorder.
    J Clin Psychiatry; 1989 Jun; 50(6):231-2. PubMed ID: 2498297
    [No Abstract]   [Full Text] [Related]  

  • 36. Response of obsessive-compulsive disorder and trichotillomania to serotonin reuptake blockers.
    Graae F; Gitow A; Piacentini J; Jaffer M; Liebowitz M
    Am J Psychiatry; 1992 Jan; 149(1):149-50. PubMed ID: 1728180
    [No Abstract]   [Full Text] [Related]  

  • 37. Manic behaviors associated with fluoxetine in three 12- to 18-year-olds with obsessive-compulsive disorder.
    Go FS; Malley EE; Birmaher B; Rosenberg DR
    J Child Adolesc Psychopharmacol; 1998; 8(1):73-80. PubMed ID: 9639082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of treatment-refractory obsessive compulsive disorder patients.
    Dominguez RA; Mestre SM
    J Clin Psychiatry; 1994 Oct; 55 Suppl():86-92. PubMed ID: 7961537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A second case of mania associated with fluoxetine.
    Turner SM; Jacob RG; Beidel DC; Griffin S
    Am J Psychiatry; 1985 Feb; 142(2):274-5. PubMed ID: 3871593
    [No Abstract]   [Full Text] [Related]  

  • 40. Dystonic reaction associated with fluvoxamine.
    George MS; Trimble MR
    J Clin Psychopharmacol; 1993 Jun; 13(3):220-1. PubMed ID: 8354740
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.